Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity.

Saved in:

Bibliographic Details
Title:	Peptide receptor radionuclide therapy with ⁹⁰Y-DOTATATE/⁹⁰Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity.
Authors:	Vinjamuri, S¹, Gilbert, T M², Banks, M³, McKane, G¹, Maltby, P¹, Poston, G³, Weissman, H⁴, Palmer, D H⁵, Vora, J⁶, Pritchard, D M⁷, Cuthbertson, D J²
Source:	British Journal of Cancer. 4/16/2013, Vol. 108 Issue 7, p1440-1448. 9p. 5 Charts, 3 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2013.103